The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid
Abstract
Background: The diagnosis of invasive pulmonary aspergillosis (IPA) remains challenging. Culture and histopathological examination of bronchoalveolar lavage (BAL) fluid are useful but have suboptimal sensitivity and in the case of culture may require several days for fungal growth to be evident. Detection of Aspergillus DNA in BAL fluid by quantitative PCR (qPCR) offers the potential for earlier diagnosis and higher sensitivity. It is important to adopt quality control measures in PCR assays to address false positives and negatives which can hinder accurate evaluation of diagnostic performance. Methods: BAL fluid from 94 episodes of pneumonia in 81 patients was analyzed. Thirteen episodes were categorized as proven or probable IPA using Mycoses Study Group criteria. The pellet and the supernatant fractions of the BAL were separately assayed. A successful extraction was confirmed with a human 18S rRNA gene qPCR. Inhibition in each qPCR was measured using an exogenous DNA based internal amplification control (IAC). The presence of DNA from pathogens in the Aspergillus genus was detected using qPCR targeting fungal 18S rRNA gene. Results: Human 18S rRNA gene qPCR confirmed successful DNA extraction of all samples. IAC detected some degree of initial inhibition in 11 samples. When culture was used to diagnose IPA, the sensitivity and specificity were 84.5% and 100% respectively. Receiver-operating characteristic analysis of qPCR showed that a cutoff of 13 fg of Aspergillus genomic DNA generated a sensitivity, specificity, positive and negative predictive value of 77%, 88%, 50%, 96% respectively. BAL pellet and supernatant analyzed together resulted in sensitivity and specificity similar to BAL pellet alone. Some patients did not meet standard criteria for IPA, but had consistently high levels of Aspergillus DNA in BAL fluid by qPCR. Conclusion: The Aspergillus qPCR assay detected Aspergillus DNA in 76.9% of subjects with proven or probable IPA when the concentrated BAL fluid pellet fraction was used for diagnosis. There was no benefit from analyzing the BAL supernatant fraction. Use of both extraction and amplification controls provided optimal quality control for interpreting qPCR results and therefore may increase our understanding of the true potential of qPCR for the diagnosis of IPA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PCR inhibition was monitored using an internal amplification control assay [19], and samples were considered inhibited if delayed by 2.0 or more cycles.”
From Urethral Microbiota in Men: Association of Haemophilus influenzae and Mycoplasma penetrans With Nongonococcal Urethritis (2021) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aspergillus fumigatus and Aspergillosis
Latgé, J.-P. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.2.310 · Cited by 2,307
Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997
McNeil, M. M., Nash, S. L., Hajjeh, R. A., Phelan, M. A., Conn, L. A., Plikaytis, B. D., & Warnock, D. W. (2001) · Clinical Infectious Diseases · doi:10.1086/322606 · Cited by 657
Research works printed but not linked: 35
- Segal BH, Walsh TJ: Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med. 2006, 173 (7): 707-717. 10.1164/rccm.200505-727SO. · DOI · Paper page
- Munoz P, Guinea J, Bouza E: Update on invasive pulmonary aspergillosis: clinical and diagnostic aspects. Clin Microbiol Infect. 2006, 12 Suppl 7: 24-39. 10.1111/j.1469-0691.2006.01603.x. · DOI
- Reichenberger F, Habicht JM, Gratwohl A, Tamm M: Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients. Eur Respir J. 2002, 19 (4): 743-755. 10.1183/09031936.02.00256102. · DOI
- Reichenberger F, Habicht J, Matt P, Frei R, Soler M, Bolliger CT, Dalquen P, Gratwohl A, Tamm M: Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplant. 1999, 24 (11): 1195-1199. 10.1038/sj.bmt.1702045. · DOI
- Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ: The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med. 1992, 86 (3): 243-248. 10.1016/S0954-6111(06)80062-4. · DOI
- Saito H, Anaissie EJ, Morice RC, Dekmezian R, Bodey GP: Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia. Chest. 1988, 94 (4): 745-749. 10.1378/chest.94.4.745. · DOI
- Adam O, Auperin A, Wilquin F, Bourhis JH, Gachot B, Chachaty E: Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis. 2004, 38 (6): 917-920. 10.1086/383148. · DOI · Paper page
- Aquino VR, Goldani LZ, Pasqualotto AC: Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis. Mycopathologia. 2007, 163 (4): 191-202. 10.1007/s11046-007-9010-2. · DOI
- Kedzierska A, Kochan P, Pietrzyk A, Kedzierska J: Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1-->3)-beta-D-glucan antigens. Eur J Clin Microbiol Infect Dis. 2007, 26 (11): 755-766. 10.1007/s10096-007-0373-6. · DOI
- Tuon FF: A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev Iberoam Micol. 2007, 24 (2): 89-94. · DOI
- Buchheidt D, Baust C, Skladny H, Ritter J, Suedhoff T, Baldus M, Seifarth W, Leib-Moesch C, Hehlmann R: Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin Infect Dis. 2001, 33 (4): 428-435. 10.1086/321887. · DOI
- Hayette MP, Vaira D, Susin F, Boland P, Christiaens G, Melin P, De Mol P: Detection of Aspergillus species DNA by PCR in bronchoalveolar lavage fluid. J Clin Microbiol. 2001, 39 (6): 2338-2340. 10.1128/JCM.39.6.2338-2340.2001. · DOI
- Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA: Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol. 2004, 42 (12): 5517-5522. 10.1128/JCM.42.12.5517-5522.2004. · DOI · Paper page
- Raad I, Hanna H, Huaringa A, Sumoza D, Hachem R, Albitar M: Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL. Chest. 2002, 121 (4): 1171-1176. 10.1378/chest.121.4.1171. · DOI
- Rantakokko-Jalava K, Laaksonen S, Issakainen J, Vauras J, Nikoskelainen J, Viljanen MK, Salonen J: Semiquantitative detection by real-time PCR of Aspergillus fumigatus in bronchoalveolar lavage fluids and tissue biopsy specimens from patients with invasive aspergillosis. J Clin Microbiol. 2003, 41 (9): 4304-4311. 10.1128/JCM.41.9.4304-4311.2003. · DOI
- Sanguinetti M, Posteraro B, Pagano L, Pagliari G, Fianchi L, Mele L, La Sorda M, Franco A, Fadda G: Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2003, 41 (8): 3922-3925. 10.1128/JCM.41.8.3922-3925.2003. · DOI
- Spiess B, Buchheidt D, Baust C, Skladny H, Seifarth W, Zeilfelder U, Leib-Mosch C, Morz H, Hehlmann R: Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients. J Clin Microbiol. 2003, 41 (5): 1811-1818. 10.1128/JCM.41.5.1811-1818.2003. · DOI
- Paterson RR: Internal amplification controls have not been employed in fungal PCR hence potential false negative results. J Appl Microbiol. 2007, 102 (1): 1-10. 10.1111/j.1365-2672.2006.03220.x. · doi:10.1111/j.1365-2672.2006.03220.x
- Loeffler J, Hebart H, Bialek R, Hagmeyer L, Schmidt D, Serey FP, Hartmann M, Eucker J, Einsele H: Contaminations occurring in fungal PCR assays. J Clin Microbiol. 1999, 37 (4): 1200-1202. · DOI · Paper page
- Bretagne S: Molecular diagnostics in clinical parasitology and mycology: limits of the current polymerase chain reaction (PCR) assays and interest of the real-time PCR assays. Clin Microbiol Infect. 2003, 9 (6): 505-511. 10.1046/j.1469-0691.2003.00677.x. · DOI
- Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ: Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002, 34 (1): 7-14. 10.1086/323335. · DOI · Paper page
- Limaye AP, Huang ML, Leisenring W, Stensland L, Corey L, Boeckh M: Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients. J Infect Dis. 2001, 183 (3): 377-382. 10.1086/318089. · DOI
- Ferns RB: Evaluation of the role of real-time PCR in the diagnosis of invasive aspergillosis. Leuk Lymphoma. 2006, 47 (1): 15-20. 10.1080/10428190500244233. · doi:10.1080/10428190500244233
- Ou CY, Moore JL, Schochetman G: Use of UV irradiation to reduce false positivity in polymerase chain reaction. Biotechniques. 1991, 10 (4): 442, 444, 446-
- Wages JM, Cai D, Fowler AK: Removal of contaminating DNA from PCR reagents by ultrafiltration. Biotechniques. 1994, 16 (6): 1014-1017.
- Jordan JA, Durso MB: Comparison of 16S rRNA gene PCR and BACTEC 9240 for detection of neonatal bacteremia. J Clin Microbiol. 2000, 38 (7): 2574-2578. · DOI
- Loffler J, Hebart H, Schumacher U, Reitze H, Einsele H: Comparison of different methods for extraction of DNA of fungal pathogens from cultures and blood. J Clin Microbiol. 1997, 35 (12): 3311-3312. · DOI · Paper page
- Fredricks DN, Smith C, Meier A: Comparison of six DNA extraction methods for recovery of fungal DNA as assessed by quantitative PCR. J Clin Microbiol. 2005, 43 (10): 5122-5128. 10.1128/JCM.43.10.5122-5128.2005. · DOI · Paper page
- Griffiths LJ, Anyim M, Doffman SR, Wilks M, Millar MR, Agrawal SG: Comparison of DNA extraction methods for Aspergillus fumigatus using real-time PCR. J Med Microbiol. 2006, 55 (Pt 9): 1187-1191. 10.1099/jmm.0.46510-0. · DOI
- Hoorfar J, Malorny B, Abdulmawjood A, Cook N, Wagner M, Fach P: Practical considerations in design of internal amplification controls for diagnostic PCR assays. J Clin Microbiol. 2004, 42 (5): 1863-1868. 10.1128/JCM.42.5.1863-1868.2004. · doi:10.1128/jcm.42.5.1863-1868.2004
- Caliendo AM, Hewitt PL, Allega JM, Keen A, Ruoff KL, Ferraro MJ: Performance of a PCR assay for detection of Pneumocystis carinii from respiratory specimens. J Clin Microbiol. 1998, 36 (4): 979-982. · DOI
- Bretagne S, Costa JM, Marmorat-Khuong A, Poron F, Cordonnier C, Vidaud M, Fleury-Feith J: Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR. J Clin Microbiol. 1995, 33 (5): 1164-1168. · DOI · Paper page
- Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F, Villard O, Liu KL, Natarajan-Ame S, Lutz P, Dufour P, Bergerat JP, Candolfi E: Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol. 2002, 20 (7): 1898-1906. 10.1200/JCO.2002.07.004. · DOI · Paper page
- Pfeiffer CD, Fine JP, Safdar N: Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis. 2006, 42 (10): 1417-1427. 10.1086/503427. · DOI · Paper page
- Spreadbury C, Holden D, Aufauvre-Brown A, Bainbridge B, Cohen J: Detection of Aspergillus fumigatus by polymerase chain reaction. J Clin Microbiol. 1993, 31 (3): 615-621. · DOI
Cited by
Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Recent advances in quantitative PCR (qPCR) applications in food microbiology
Postollec, F., Falentin, H., Pavan, S., Combrisson, J., & Sohier, D. (2011) · Food Microbiology · doi:10.1016/j.fm.2011.02.008 · Cited by 479
Temporal Variability of Human Vaginal Bacteria and Relationship with Bacterial Vaginosis
Srinivasan, S., Liu, C., Mitchell, C. M., Fiedler, T. L., Thomas, K. K., Agnew, K. J., Marrazzo, J. M., & Fredricks, D. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010197 · Cited by 465
Self-citationMolecular and Nonmolecular Diagnostic Methods for Invasive Fungal Infections
Arvanitis, M., Anagnostou, T., Fuchs, B. B., Caliendo, A. M., & Mylonakis, E. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00091-13 · Cited by 353
Denning, D. W., Park, S., Lass-Florl, C., Fraczek, M. G., Kirwan, M., Gore, R., Smith, J., Bueid, A., Moore, C. B., Bowyer, P., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir179 · Cited by 313
Metadata
- Authors
- Khot, P. D., Ko, D. L., Hackman, R. C., & Fredricks, D. N.
- Venue
- BMC Infectious Diseases
- Published
- 2008-05-29
- Volume
- 8
- Issue
- 1
- ISSN
- 1471-2334
- Cited by
- 121
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. https://app.cochat.ai/papers/10.1186/1471-2334-8-73
- The paper
- Khot, P. D., Ko, D. L., Hackman, R. C., & Fredricks, D. N. (2008). Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. BMC Infectious Diseases. https://doi.org/10.1186/1471-2334-8-73
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.